Navigation Links
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
Date:9/28/2007

CAMBRIDGE, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced a strategic restructuring. As part of the restructuring, Idenix has amended the collaboration agreement with Novartis Pharma AG related to Tyzeka(R)/Sebivo(R). Per the amended agreement, Idenix will discontinue all development, manufacturing and commercial activities for Tyzeka/Sebivo. Novartis will continue these activities and have full responsibility for ongoing and future clinical trials and regulatory filings related to Tyzeka/Sebivo. Additionally, Idenix will receive a royalty on worldwide product sales. As a result of these changes, Idenix is reducing its workforce by approximately 100 positions, the majority of which support the development and commercialization of Tyzeka/Sebivo in the United States and Europe. Following this reduction, Idenix will have approximately 200 employees at the company. The company anticipates that this action will reduce its cash burn rate by between 40 percent and 50 percent.

"This has been a challenging time in the evolution of our company and we have re-evaluated our strategic plan and our organizational structure," said Jean-Pierre Sommadossi, Ph.D., chairman and chief executive officer of Idenix. "We made a strategic decision to focus all of our resources on our hepatitis C and HIV/AIDS discovery and development programs; as such, we have discontinued the development of valtorcitabine for the treatment of hepatitis B and have changed our agreement for Tyzeka/Sebivo to a royalty stream arrangement. These decisions will enable us to concentrat
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Front-face detection for high-concentrate, opaque or solid sample
4. Concentrated solar energy project wins Innovation Days prizes
5. Wisconsin stands at the center of scientific efforts to avert flu epidemics
6. Thompsons HHS legacy will include efforts to combat disease in Africa
7. Efforts to avoid friendly fire spawned ancestor of todays RFID
8. Manufacturing group says efforts led to big improvements
9. Madison grid computing efforts attack big research questions
10. Californian stem-cell efforts get new rules, attract lawsuits
11. Tech Council passes E-Learning efforts for Northern Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)..., Company Introduces New Trade Name Onrigin(TM)... 4 VION PHARMACEUTICALS...ral announcements related to events in connection ...l Meeting at the Moscone Center in San Francisco f... Presentation , , The Company announced t...
(Date:12/4/2008)...OUNTAIN VIEW, Calif., Dec. 4 Based...tions, Frost & Sullivan recognizes Honeywell E... of the Year Award. Honeywell Enraf,s comprehensiv...an accurate mixture of fuels, chemicals and other ...jection rate. Honeywell Enraf,s blending equipment...
(Date:12/4/2008)...ARIS, December 4 ExonHit... diagnostic discovery company, is pleased to,anno...National Institute of,Industrial Property) during...,(Innovation Trophy). , "Since its incepti...and,to protect the value of its intellectual prop...
(Date:12/3/2008)..., - Additional Pipeline Product Agreement Execu...-, , , MONTREAL and BAGSVAERD, Denmark, De...ogies Inc. (TSX:CJB) and Novozymes Biopharma UK Lt...ced today that the Companies have entered into a l...ch Novozymes Biopharma will exclusively supply its...
Breaking Biology Technology:Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support 2Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support 3ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 2ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 3
...i-Yu Lin, Bio-Rad Laboratories, , ...rmat for electroporation of mammalian tissue cultu...n than a single exponential decay , pulse...ponents of the , double pulse revealed th..., the first, high voltage pulse and not to ...
...i Tian, PhD, Bio-Rad Laboratories, 2000 Alfred,N... , The Benchmark Plus microplate reade... reader from Bio-Rad that offers superior conve...Benchmark Plus is controlled by Microplate Manager...igned in Microplate Manager software (version 5.1 ...
..., R. Geremia, M. Van,Montagu, and A. Herrera-Est...teit Gent, B-9000 Gent,Belgium, , ...l transformation protocols call for the addition o...glycol (PEG) following the initial , peri...uld also be useful , for introducing gene...
, , , , , , back to top
Other Biology Technology:Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses 2Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses 3Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses 4Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses 5Benchmark Plus Microplate Reader Scan Well Feature 2Benchmark Plus Microplate Reader Scan Well Feature 3Transformation of Filamentous Fungi by High-Voltage Electroporation 2Transformation of Filamentous Fungi by High-Voltage Electroporation 3Transformation of Filamentous Fungi by High-Voltage Electroporation 4Transformation of Filamentous Fungi by High-Voltage Electroporation 5Transformation of Filamentous Fungi by High-Voltage Electroporation 6Transformation of Filamentous Fungi by High-Voltage Electroporation 7Transformation of Filamentous Fungi by High-Voltage Electroporation 8
(Date:12/3/2008)...As the United States continues to develop alternat...dence, cellulosic-based ethanol has emerged as one...n stover remains the most popular source available...ated with the removal of corn fodder as a cellulos...nmental concern. , In the November-December 20...
(Date:12/3/2008)...of the first tandem mission between ERS-2 and Envi...ogether again to help improve our understanding of...and Envisat, the largest environmental satellite e...R) instruments that provide high resolution images...ore SAR images of the same site, slight alteration...
(Date:12/3/2008)...d as safe for pregnancy - other asthma drugs have ...ually keep using the same asthma drugs they were u...re the best studied and can be regarded as safe. M...ary however. According to the German Institute for...re data from trials could reassure women who worry...
(Date:12/2/2008)...ire/ -- Neurotechnology,( http://www.neurotechnol...,technologies, today announced that the Bangladesh...chnology to identify duplicate registrations in th...egistration Project registered,more than 80 milli...echnology.,After evaluating a number of biometric...
Breaking Biology News(10 mins):Managing carbon loss 2ESA satellites flying in formation 2Pregnant women with asthma can be more confident about some medicines 2Bangladesh Voter Registration Project Now Using MegaMatcher Biometric Technology to Detect and Prevent Duplicate Registrations 2Bangladesh Voter Registration Project Now Using MegaMatcher Biometric Technology to Detect and Prevent Duplicate Registrations 3New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 1New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 2New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 3New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 4New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 5New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 6New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 7New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 8Global Pharmaceutical Launches 3A Best Practices for Winning Product Launch Successes 19615 1Global Pharmaceutical Launches 3A Best Practices for Winning Product Launch Successes 19615 2Message to Nebraska Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19611 1Message to Nebraska Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19611 2Message to Nebraska Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19611 3Industry Executives Finding Value in Shift of Scientific Publications 5484 1Industry Executives Finding Value in Shift of Scientific Publications 5484 2
... be able to understand the brain until they can pu...ns of neurons are interconnected. Now, researchers... jumped what many believe to be a major hurdle to ...ctions to a single neuron. , In the March 1 issue ...w they modified the deadly rabies virus, turning i...
..., an international team of 19 researchers calls fo...ing on extinction rates. The researchers, led by D...atical models indicate that many species could be ...ies became extinct during the past 2.5 million yea...uggest that this "Quaternary conundrum" arises bec...
...ate Epstein-Barr viruses inside tumors as a way t...nipulated to destroy their tumors. They say this s...ancers associated with Epstein-Barr, including at ...ryngeal and gastric cancers. , In the March 1 issu...sts and oncologists from Johns Hopkins Medical Ins...
...calorie intake can increase health and longevity. ...ia) and his collaborators* have discovered that re...ce many of the health and longevity benefits of li...includes anti-cancer effects. , They are using th...que to find drugs which mimic this longevity effec...
Other Biology News:Deconstructing brain wiring, one neuron at a time 2Deconstructing brain wiring, one neuron at a time 3Researchers wake up viruses inside tumors to image and then destroy cancers 2Researchers wake up viruses inside tumors to image and then destroy cancers 3It's never too late to get it back! Aging interrupted 2